Gilead Sciences Competitors and Similar CompaniesClear all
Gilead Sciences's competitors and similar companies include Novo Nordisk, Catalent, Biogen, ViiV Healthcare, Bristol Myers Squibb and AbbVie.
 Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines. |  Novo Nordisk Novo Nordisk is a healthcare company that designs and manufactures pharmaceutical products. |  Catalent Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  ViiV Healthcare ViiV Healthcare is a company focused on research and development of medicines for people living with HIV. |  Bristol Myers Squibb Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products. |  AbbVie AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies. | |
Founding Date | Founding Date 1987 | Founding Date 1923 | Founding Date 2007 | Founding Date 1978 | Founding Date 2009 | Founding Date 1887 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||||
Locations | Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more | Locations Bagsværd, DK HQ Tirana, AL Boufarik, DZ Hydra, DZ Tizi Ouzou, DZ Buenos Aires, AR North Sydney, AU see more | Locations Somerset, US HQ Buenos Aires, AR Bruxelles, BE Charleroi, BE Charleroi, BE Charleroi, BE Indaiatuba, BR see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Princeton, US HQ Mulgrave, AU Pinewood, AU Wien, AT Braine L'alleud, BE Bruxelles, BE São Paulo, BR see more | Locations North Chicago, US HQ Alger, DZ Buenos Aires, AR Mascot, AU Wien, AT Wavre, BE Sarajevo, BA see more | |
Employees | Employees 18,0006% increase | Employees 69,260 | Employees 17,8006% decrease | Employees 7,57013% decrease | Employees 1,844 | Employees 34,1001% decrease | Employees 50,000 |
Valuation ($) | Valuation ($) 105.4 b | Valuation ($) 599.3 b | Valuation ($) 11 b | Valuation ($) 27.5 b | Valuation ($) N/A | Valuation ($) 97.8 b | Valuation ($) 343.3 b |
Financial | |||||||
Revenue (est.) | Revenue (est.) $27.1b (FY, 2023) | Revenue (est.) kr232.3b (FY, 2023) | Revenue (est.) $4.4b (FY, 2024) | Revenue (est.) $9.8b (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $45b (FY, 2023) | Revenue (est.) $54.3b (FY, 2023) |
Cost of goods | Cost of goods $6.5b (FY, 2023) | Cost of goods kr30.8b (FY, 2023) | Cost of goods $3.4b (FY, 2024) | Cost of goods $2.5b (FY, 2023) | Cost of goods N/A | Cost of goods $10.7b (FY, 2023) | Cost of goods $20.4b (FY, 2023) |
Gross profit | Gross profit $20.6b (FY, 2023) | Gross profit kr202b (FY, 2023) | Gross profit $953m (FY, 2024) | Gross profit $7.3b (FY, 2023) | Gross profit N/A | Gross profit $34.3b (FY, 2023) | Gross profit $33.9b (FY, 2023) |
Net income | Net income $5.6b (FY, 2023) | Net income kr83.7b (FY, 2023) | Net income ($1b) (FY, 2024) | Net income $1.2b (FY, 2023) | Net income N/A | Net income $8b (FY, 2023) | Net income $4.9b (FY, 2023) |
Operating ⚠ | |||||||
Countries | Countries 35 (FY, 2021) | Countries N/A | Countries 80 (FY, 2023) | Countries N/A | Countries N/A | Countries N/A | Countries 70 (FY, 2022) |
Manufacturing Facilities | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities 8 (FY, 2021) | Manufacturing Facilities 19 (FY, 2022) |
Phase I Trials Products (Oncology) | Phase I Trials Products (Oncology) 7 (FY, 2019) | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) 20 (FY, 2021) | Phase I Trials Products (Oncology) N/A |
Phase II Trials Products (Oncology) | Phase II Trials Products (Oncology) 1 (FY, 2021) | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) 15 (FY, 2021) | Phase II Trials Products (Oncology) N/A |
Phase III Trials Products | Phase III Trials Products 9 (FY, 2021) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 9 (Q2, 2022) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A |
Phase III Trials Products (Oncology) | Phase III Trials Products (Oncology) 4 (FY, 2021) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 7 (FY, 2021) | Phase III Trials Products (Oncology) N/A |
Products | Products 21 (FY, 2021) | Products N/A | Products 8 k (FY, 2023) | Products N/A | Products N/A | Products N/A | Products N/A |
Research and Development Centers | Research and Development Centers N/A | Research and Development Centers N/A | Research and Development Centers N/A | Research and Development Centers N/A | Research and Development Centers N/A | Research and Development Centers 11 (FY, 2021) | Research and Development Centers 14 (FY, 2020) |
Funding | |||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 650m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 15.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Novo Nordisk
HQ
Bagsværd, DK
Employees
69,260
Novo Nordisk is a healthcare company that designs and manufactures pharmaceutical products.
View companyCatalent
HQ
Somerset, US
Employees
17,800↓ 6% decrease
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
View companyBiogen
HQ
Cambridge, US
Employees
7,570↓ 13% decrease
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyViiV Healthcare
HQ
London, GB
ViiV Healthcare is a company focused on research and development of medicines for people living with HIV.
View company